documents: FDA-2020-N-1088-0014
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2020-N-1088-0014 | FDA | FDA-2020-N-1088 | Microbiology Devices; Reclassification of Nucleic Acid-Based Hepatitis C Virus Ribonucleic Acid Assay Devices, Renamed to Nucleic Acid-Based Hepatitis C Virus Ribonucleic Acid Tests | Rule | Final Rule | 2021-11-22T05:00:00Z | 2021 | 11 | 2021-11-22T05:00:00Z | 2021-11-22T15:44:54Z | 2021-25379 | 0 | 0 | 0900006484e71238 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref